BioSpace News Archive

Zucara Therapeutics Inc. announced that it has closed a US$21 million Series A Financing led by the Perceptive Xontogeny Venture Fund.

GM expects to deliver first 20,000 masks April 8, and to produce an estimated 1.5 million masks a month once at full capacity

LunellaTM LLC launched this week, a service that simplifies and makes sleep apnea diagnosis more accessible by giving consumers an at-home alternative to the traditional in-lab sleep study as a first line diagnostic tool.

MEI Pharma, Inc. announced that the U.S. Food and Drug Administration granted Fast Track designation to ME-401, MEI’s investigational selective oral inhibitor of phosphatidylinositol 3-kinase delta for the treatment of adult Patients with relapsed or refractory follicular lymphoma who have received at least two prior systemic therapies.

The novel single-use micro-endoscope with multiple working channels, eliminates the risk of transmitting infections between patients.

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail..

Revenues and Net Profits Maintain Solid Growth with Remarkable Globalization Innovation Capability

All AKR-001 dose groups met the primary endpoint, with statistically significant absolute reductions in liver fat of 12-14%

CellFE, Inc., an innovative startup developing a microfluidics based device to deliver gene-editing molecules, announced it has completed a $4.8 million Series Seed round of financing.

Bionomics Limited announced that a paper describing the pharmacology of BNC375, a novel positive allosteric modulator of the alpha 7 nicotinic acetylcholine receptor, was published online on February 24, 2020 in the peer-reviewed publication Journal of Pharmacology and Experimental Therapeutics.